Trial intelligence / Profile preview

PENG Block Injectate Spread Imaging Study

NCT06062134Completed

Start
Oct 2023
Primary completion
Dec 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label, single-arm trial of ropivacaine in postoperative pain. Primary endpoint: Concentration of the local anesthetic reaching specific anatomical areas of interest around the hip joint at 2 hours. Started Oct 2023; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06062134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06062134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call